Clinical Trials Logo

Filter by:
NCT ID: NCT05044949 Completed - Healthy Volunteers Clinical Trials

Study Evaluating the Safety and Tolerability of a Probioitc

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The rationale for the current study is to initially evaluate the safety and tolerability of a novel strain of the probiotic Limosilactobacillus reuteri (L. reuteri) in healthy volunteers.

NCT ID: NCT05044065 Recruiting - Pancreatic Cancer Clinical Trials

Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)

PREV-Ex
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

In patients with cancer, resistance training appears to be a safe and effective exercise modality to increase both lean muscle mass and strength, as well as attenuates cancer-related fatigue. It may serve as a feasible intervention in these patients to mitigate cachexia, especially if implemented before the onset of cancer cachexia or in a pre-cachectic state. This study is a multicenter randomized controlled trial that will compare a blood flow restricted resistance training intervention during the pre- (prehabilitation) and post-operative (rehabilitation) phase in patients with pancreatic, biliary tract and liver cancer, versus usual care on skeletal muscle and other health-related outcomes.

NCT ID: NCT05043506 Completed - Clinical trials for Metastatic Breast Cancer

European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies

EUCHARIS
Start date: February 8, 2022
Phase:
Study type: Observational

A retrospective observational analysis of de-identified data from a multinational medical record review to describe patient characteristics, treatment patterns, and effectiveness of palbociclib + AI as first-line therapy among adult patients with HR+/HER2- advanced breast cancer (ABC) in Europe

NCT ID: NCT05043103 Recruiting - Clinical trials for Advanced Parkinson Disease

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

ELEGANCE
Start date: July 6, 2021
Phase:
Study type: Observational

This observational study is designed to collect data on the use of the drug Lecigon® in daily clinical practice. The study is organised and funded by a pharmaceutical company called Britannia Pharmaceuticals Ltd (Britannia). Lecigon® is prescribed by physicians in advanced Parkinson's disease when patients suffer from uncontrollable fluctuations in mobility, so-called motor fluctuations, which cannot be adjusted well with oral treatment, i.e. medication for swallowing. In this study, data on the effect and possible side effects from everyday treatment with Lecigon® will be collected and scientifically evaluated. The study is intended to supplement the results of previous clinical studies with clinical data in routine medical care, collected from approximately 300 patients.

NCT ID: NCT05040048 Completed - Parkinson's Disease Clinical Trials

Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease

AETIONOMY
Start date: September 4, 2015
Phase:
Study type: Observational

The AETIONOMY project will generate a refined taxonomy and testable mechanisms underlying the derived stratification of patients.

NCT ID: NCT05039515 Recruiting - Clinical trials for Fibrodysplasia Ossificans Progressiva

A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).

FALKON
Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

Fibrodysplasia Ossificans Progressiva (FOP) is a rare, severely disabling disease characterized by the presence of bone in soft tissue where bone normally does not exist, known as Heterotopic Ossification (HO). It is often associated with painful, recurrent episodes of soft tissue swelling (flare-ups) that lead to abnormal stiffening and immobility (ankyloses) of major joints with cumulative and irreversible loss of movement and disability. This study will evaluate the efficacy of 2 dosing regimens of IPN60130 in inhibiting new HO volume compared with placebo (a dummy treatment) in adult and paediatric participants with FOP. It will be assessed by a scan (provides internal images of the body) called low dose Whole Body Computed Tomography (WBCT), excluding head. Adults and participants 5 years of age or older are also eligible for a sub study to evaluate HO lesions assessed by another type of scan, Fluorine-18-labelled natrium fluoride Positron Emission Tomography-Computed Tomography ([18F]NaF PET-CT ).

NCT ID: NCT05039203 Enrolling by invitation - Clinical trials for Urinary Tract Infections

Bacteriuria and Indwelling Urinary Catheter.

Start date: May 24, 2022
Phase:
Study type: Observational

Investigation of 1. The incidence of symptomatic bacteriuria during four weeks after removal of an IUC in inpatients at a rehabilitation clinic for patients ≥ 65 years compared with the incidence of symptomatic bacteriuria among inpatients not treated with an IUC and 2. For how long does ABU persist in inpatients at a rehabilitation clinic for patients ≥ 65 years during a follow-up time of four weeks after IUC-removal?

NCT ID: NCT05039099 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Start date: September 2, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, PK, and PD of AP-101 in participants with fALS and sALS.

NCT ID: NCT05038917 Recruiting - Clinical trials for Endoscopic Surgical Procedure

Sedation for Endoscopic Procedures

SEEUPP
Start date: March 30, 2020
Phase:
Study type: Observational [Patient Registry]

Endoscopic procedures for biliary strictures, stenting or drainage (ERCP) and ultrasonic imaging or biopsies (EUS) are performed under sedation or anesthesia. The main purpose of the study is to evaluate aspects of procedure treatability and patients´ quality of recovery.

NCT ID: NCT05038865 Recruiting - Quality of Life Clinical Trials

The Effect of Malocclusions on Oral Health Related Quality of Life

Start date: December 1, 2021
Phase:
Study type: Observational

Malocclusions in adolescents may affect oral health related quality of life. The study aims at; 1. Evaluating two instruments measuring oral health related quality of life; "Child Perceptions Questionnaire 11-14" (CPQ 11-14) short form and "Psychosocial Impact of Dental Aesthetics Questionnaire" (PIDAQ). 2. Comparing differences in oral health related quality of life in; 1. adolescents with different types of malocclusion and without malocclusions 2. individuals of different genders and socioeconomic status 3. Longitudinally evaluating differences in oral health related quality of life; 1. before, during and after orthodontic treatment 2. in untreated individuals (without malocclusion) over time